Precision Medicine in GI Cancers: Targeting the DNA Damage Response and Repair Pathway

Part of the Surgical Grand Rounds Series - Michael Pishvaian, MD, PhD explains how to evaluate the frequency of actionable molecular alternations in GI cancers. He also reviews current data of targeted therapy for biomarker-selected patients with advanced GI cancers. Dr. Pishvaian identifies the potential for targeting DNA damage response and repair for the treatment of advanced pancreatic cancer.